Dr. J.M. Gamble
Cross appointment with the Faculty of Medicine (Family Medicine)
Dr. Gamble began his academic training at Lakehead University in Thunder Bay Ontario where he completed a Bachelor of Science degree in Biology. Subsequently, he completed a Bachelor of Science degree in Pharmacy at the University of Alberta, where he also received his Master of Science in Clinical Epidemiology and Doctor of Philosophy degree from the School of Public Health.
He joined the School of Pharmacy at Memorial University of Newfoundland in 2012 and holds a cross appointment in the Faculty of Medicine within the Discipline of Family Medicine.
Research Areas of Interest:
• Post-marketing drug safety and effectiveness research
• Diabetes health outcomes
• Pharmaceutical policy evaluation
• Evidence-based monitoring of medicines
• Knowledge synthesis of drug effects
His current research program focuses on the comparative safety and effectiveness of cardiometabolic drugs, in particular mediations used to treat type 2 diabetes.
Teaching Areas of Interest: Pharmacoepidemiology, evidence-based practice, systematic reviews and meta-analysis
• Comparative Cardiovascular Effects of Incretin-based Medications
• Comparative Safety of Incretin-based Medications
• Impact of Insulin Therapy on Cardiovascular Outcomes in Patients with Type 2 Diabetes Teaching
- New Investigator Award, Canadian Institutes of Health Research, 2013
- 2018 Clinician Scientist Award, Canadian Diabetes Association,
- 2018 George A Burbidge Memorial Award, Recognition for the highest overall combined grade obtained on a first attempt in the Pharmacy Examining Board of Canada Qualifying Examination - Part I and II, 2005
1. Gamble JM, Johnson JA, McAlister FA, Majumdar SR, Simpson SH, Eurich DT. Impact of Exposure Misclassification Due to Incomplete Drug Data in Observational Studies of Drug Safety and Effectiveness: a cohort study. Clinical Therapeutics (in press; online 14Jan2015).
2. Gamble JM. An Introduction to the Fundamentals of Cohort and Case-Control Studies. Can J Hosp Pharm 2014;67:366-372. Available: http://www.cjhp-online.ca/index.php/cjhp/article/view/1391/2014 [Impact factor n/a] PMID: 25364019
3. Gamble JM, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT. Medication Transitions and Polypharmacy in Older Adults Following Acute Care. Therapeutics and Clinical Risk Management 2014;10:189-196. DOI: 10.2147/TCRM.S58707 [Impact factor 1.4] PMID: 2467223
Phone: (709) 777-7977